Central Glucagon-like Peptide-1 Receptor Signaling via Brainstem Catecholamine Neurons Counteracts Hypertension in Spontaneously Hypertensive Rats

Kenichi Katsurada, Masanori Nakata, Toshinobu Saito, Boyang Zhang, Yuko Maejima, Shyam S. Nandi, Neeru M. Sharma, Kaushik P. Patel, Kazuomi Kario, Toshihiko Yada

Research output: Contribution to journalArticle

Abstract

Glucagon-like peptide-1 receptor (GLP-1R) agonists, widely used to treat type 2 diabetes, reduce blood pressure (BP) in hypertensive patients. Whether this action involves central mechanisms is unknown. We here report that repeated lateral ventricular (LV) injection of GLP-1R agonist, liraglutide, once daily for 15 days counteracted the development of hypertension in spontaneously hypertensive rats (SHR). In parallel, it suppressed urinary norepinephrine excretion, and induced c-Fos expressions in the area postrema (AP) and nucleus tractus solitarius (NTS) of brainstem including the NTS neurons immunoreactive to dopamine beta-hydroxylase (DBH). Acute administration of liraglutide into fourth ventricle, the area with easy access to the AP and NTS, transiently decreased BP in SHR and this effect was attenuated after lesion of NTS DBH neurons with anti-DBH conjugated to saporin (anti-DBH-SAP). In anti-DBH-SAP injected SHR, the antihypertensive effect of repeated LV injection of liraglutide for 14 days was also attenuated. These findings demonstrate that the central GLP-1R signaling via NTS DBH neurons counteracts the development of hypertension in SHR, accompanied by attenuated sympathetic nerve activity.

Original languageEnglish (US)
Article number12986
JournalScientific reports
Volume9
Issue number1
DOIs
StatePublished - Dec 1 2019

Fingerprint

Solitary Nucleus
Inbred SHR Rats
Dopamine beta-Hydroxylase
Brain Stem
Catecholamines
Hypertension
Neurons
Area Postrema
Blood Pressure
Fourth Ventricle
Injections
Type 2 Diabetes Mellitus
Antihypertensive Agents
Norepinephrine
Glucagon-Like Peptide-1 Receptor
Liraglutide

ASJC Scopus subject areas

  • General

Cite this

Central Glucagon-like Peptide-1 Receptor Signaling via Brainstem Catecholamine Neurons Counteracts Hypertension in Spontaneously Hypertensive Rats. / Katsurada, Kenichi; Nakata, Masanori; Saito, Toshinobu; Zhang, Boyang; Maejima, Yuko; Nandi, Shyam S.; Sharma, Neeru M.; Patel, Kaushik P.; Kario, Kazuomi; Yada, Toshihiko.

In: Scientific reports, Vol. 9, No. 1, 12986, 01.12.2019.

Research output: Contribution to journalArticle

Katsurada, Kenichi ; Nakata, Masanori ; Saito, Toshinobu ; Zhang, Boyang ; Maejima, Yuko ; Nandi, Shyam S. ; Sharma, Neeru M. ; Patel, Kaushik P. ; Kario, Kazuomi ; Yada, Toshihiko. / Central Glucagon-like Peptide-1 Receptor Signaling via Brainstem Catecholamine Neurons Counteracts Hypertension in Spontaneously Hypertensive Rats. In: Scientific reports. 2019 ; Vol. 9, No. 1.
@article{ab4929b7062643539154f679eb6f0868,
title = "Central Glucagon-like Peptide-1 Receptor Signaling via Brainstem Catecholamine Neurons Counteracts Hypertension in Spontaneously Hypertensive Rats",
abstract = "Glucagon-like peptide-1 receptor (GLP-1R) agonists, widely used to treat type 2 diabetes, reduce blood pressure (BP) in hypertensive patients. Whether this action involves central mechanisms is unknown. We here report that repeated lateral ventricular (LV) injection of GLP-1R agonist, liraglutide, once daily for 15 days counteracted the development of hypertension in spontaneously hypertensive rats (SHR). In parallel, it suppressed urinary norepinephrine excretion, and induced c-Fos expressions in the area postrema (AP) and nucleus tractus solitarius (NTS) of brainstem including the NTS neurons immunoreactive to dopamine beta-hydroxylase (DBH). Acute administration of liraglutide into fourth ventricle, the area with easy access to the AP and NTS, transiently decreased BP in SHR and this effect was attenuated after lesion of NTS DBH neurons with anti-DBH conjugated to saporin (anti-DBH-SAP). In anti-DBH-SAP injected SHR, the antihypertensive effect of repeated LV injection of liraglutide for 14 days was also attenuated. These findings demonstrate that the central GLP-1R signaling via NTS DBH neurons counteracts the development of hypertension in SHR, accompanied by attenuated sympathetic nerve activity.",
author = "Kenichi Katsurada and Masanori Nakata and Toshinobu Saito and Boyang Zhang and Yuko Maejima and Nandi, {Shyam S.} and Sharma, {Neeru M.} and Patel, {Kaushik P.} and Kazuomi Kario and Toshihiko Yada",
year = "2019",
month = "12",
day = "1",
doi = "10.1038/s41598-019-49364-x",
language = "English (US)",
volume = "9",
journal = "Scientific Reports",
issn = "2045-2322",
publisher = "Nature Publishing Group",
number = "1",

}

TY - JOUR

T1 - Central Glucagon-like Peptide-1 Receptor Signaling via Brainstem Catecholamine Neurons Counteracts Hypertension in Spontaneously Hypertensive Rats

AU - Katsurada, Kenichi

AU - Nakata, Masanori

AU - Saito, Toshinobu

AU - Zhang, Boyang

AU - Maejima, Yuko

AU - Nandi, Shyam S.

AU - Sharma, Neeru M.

AU - Patel, Kaushik P.

AU - Kario, Kazuomi

AU - Yada, Toshihiko

PY - 2019/12/1

Y1 - 2019/12/1

N2 - Glucagon-like peptide-1 receptor (GLP-1R) agonists, widely used to treat type 2 diabetes, reduce blood pressure (BP) in hypertensive patients. Whether this action involves central mechanisms is unknown. We here report that repeated lateral ventricular (LV) injection of GLP-1R agonist, liraglutide, once daily for 15 days counteracted the development of hypertension in spontaneously hypertensive rats (SHR). In parallel, it suppressed urinary norepinephrine excretion, and induced c-Fos expressions in the area postrema (AP) and nucleus tractus solitarius (NTS) of brainstem including the NTS neurons immunoreactive to dopamine beta-hydroxylase (DBH). Acute administration of liraglutide into fourth ventricle, the area with easy access to the AP and NTS, transiently decreased BP in SHR and this effect was attenuated after lesion of NTS DBH neurons with anti-DBH conjugated to saporin (anti-DBH-SAP). In anti-DBH-SAP injected SHR, the antihypertensive effect of repeated LV injection of liraglutide for 14 days was also attenuated. These findings demonstrate that the central GLP-1R signaling via NTS DBH neurons counteracts the development of hypertension in SHR, accompanied by attenuated sympathetic nerve activity.

AB - Glucagon-like peptide-1 receptor (GLP-1R) agonists, widely used to treat type 2 diabetes, reduce blood pressure (BP) in hypertensive patients. Whether this action involves central mechanisms is unknown. We here report that repeated lateral ventricular (LV) injection of GLP-1R agonist, liraglutide, once daily for 15 days counteracted the development of hypertension in spontaneously hypertensive rats (SHR). In parallel, it suppressed urinary norepinephrine excretion, and induced c-Fos expressions in the area postrema (AP) and nucleus tractus solitarius (NTS) of brainstem including the NTS neurons immunoreactive to dopamine beta-hydroxylase (DBH). Acute administration of liraglutide into fourth ventricle, the area with easy access to the AP and NTS, transiently decreased BP in SHR and this effect was attenuated after lesion of NTS DBH neurons with anti-DBH conjugated to saporin (anti-DBH-SAP). In anti-DBH-SAP injected SHR, the antihypertensive effect of repeated LV injection of liraglutide for 14 days was also attenuated. These findings demonstrate that the central GLP-1R signaling via NTS DBH neurons counteracts the development of hypertension in SHR, accompanied by attenuated sympathetic nerve activity.

UR - http://www.scopus.com/inward/record.url?scp=85072403804&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85072403804&partnerID=8YFLogxK

U2 - 10.1038/s41598-019-49364-x

DO - 10.1038/s41598-019-49364-x

M3 - Article

C2 - 31537818

AN - SCOPUS:85072403804

VL - 9

JO - Scientific Reports

JF - Scientific Reports

SN - 2045-2322

IS - 1

M1 - 12986

ER -